MicroRNAs: Novel regulators in the hallmarks of human cancer

Cancer Letters

Volumn 285, Issue 2, 2009, Pages 116-126

  Ruan, Kai ^a   Fang, Xiaoguang ^a   Ouyang, Gaoliang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cancer; Hallmark; miRNAs; Oncogene; Tumor suppressor gene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; MICRORNA; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANGIOGENESIS; APOPTOSIS; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL FEATURE; GENE EXPRESSION REGULATION; GENETIC STABILITY; HUMAN; IMMUNE RESPONSE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; RNA DEGRADATION; RNA TRANSLATION; SHORT SURVEY; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS;

EID: 70349976210     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.04.031     Document Type: Review

References (144)

1. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
2. Wightman B., Ha I., and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993) 855-862
3. Lee Y.S., and Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 4 (2008) 199-227
4. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., and Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37 (2005) 766-770
5. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., and Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120 (2005) 21-24
6. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
7. Kent O.A., and Mendell J.T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25 (2006) 6188-6196
8. Williams A.E. Functional aspects of animal microRNAs. Cell. Mol. Life Sci. 65 (2008) 545-562
9. Stahlhut Espinosa C.E., and Slack F.J. The role of microRNAs in cancer. Yale J. Biol. Med. 79 (2006) 131-140
10. Zhang B., Pan X., Cobb G.P., and Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 302 (2007) 1-12
11. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., and Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99 (2002) 15524-15529
12. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., and Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 435 (2005) 828-833
13. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., and Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 447 (2007) 1130-1134
14. Croce C.M. Oncogenes and cancer. N. Engl. J. Med. 358 (2008) 502-511
15. Kumar M.S., Lu J., Mercer K.L., Golub T.R., and Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39 (2007) 673-677
16. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
17. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., and Harris C.C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
18. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103 (2006) 2257-2261
19. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
20. Elliott R.L., and Blobe G.C. Role of transforming growth factor Beta in human cancer. J. Clin. Oncol. 23 (2005) 2078-2093
21. Bueno M.J., de Castro I.P., and Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 7 (2008) 3143-3148
22. Si M.L., Zhu S., Wu H., Lu Z., Wu F., and Mo Y.Y. miR-21-mediated tumor growth. Oncogene 26 (2007) 2799-2803
23. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
24. Petrocca F., Vecchione A., and Croce C.M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 68 (2008) 8191-8194
25. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., Henderson J.M., Kutok J.L., and Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9 (2008) 405-414
26. Woods K., Thomson J.M., and Hammond S.M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem. 282 (2007) 2130-2134
27. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005) 839-843
28. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., and Mendell J.T. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40 (2008) 43-50
29. le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafre S.A., Farace M.G., and Agami R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26 (2007) 3699-3708
30. Gillies J.K., and Lorimer I.A. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6 (2007) 2005-2009
31. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., and Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 282 (2007) 23716-23724
32. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
33. Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., Wilson M., Wang X., Shelton J., Shingara J., Chin L., Brown D., and Slack F.J. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67 (2007) 7713-7722
34. Mayr C., Hemann M.T., and Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007) 1576-1579
35. Sampson V.B., Rong N.H., Han J., Yang Q., Aris V., Soteropoulos P., Petrelli N.J., Dunn S.P., and Krueger L.J. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67 (2007) 9762-9770
36. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., and Song E. let-7 Regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
37. Abdelmohsen K., Srikantan S., Kuwano Y., and Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl. Acad. Sci. USA 105 (2008) 20297-20302
38. Lin S.L., Chiang A., Chang D., and Ying S.Y. Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14 (2008) 417-424
39. Bao S., Ouyang G., Bai X., Huang Z., Ma C., Liu M., Shao R., Anderson R.M., Rich J.N., and Wang X.F. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5 (2004) 329-339
40. Ouyang G., Liu M., Ruan K., Song G., Mao Y., and Bao S. Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett. (2009) Epub ahead of print
41. Song G., Cai Q.F., Mao Y.B., Ming Y.L., Bao S.D., and Ouyang G.L. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway. Cancer Sci. 99 (2008) 1901-1907
42. Song G., Ming Y., Mao Y., Bao S., and Ouyang G. Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via {alpha}v{beta}3 integrins in human gastric cancer cells. Exp. Biol. Med. (Maywood) 233 (2008) 1537-1545
43. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9 (2005) 59-71
44. Ruan K., Bao S., and Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. (2009) Epub ahead of print
45. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., and Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 102 (2005) 13944-13949
46. Mott J.L., Kobayashi S., Bronk S.F., and Gores G.J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26 (2007) 6133-6140
47. Han J., Goldstein L.A., Gastman B.R., and Rabinowich H. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J. Biol. Chem. 281 (2006) 10153-10163
48. He X., He L., and Hannon G.J. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 67 (2007) 11099-11101
49. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., and Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26 (2007) 731-743
50. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., and Fearon E.R. p53-Mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17 (2007) 1298-1307
51. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C.J., Arking D.E., Beer M.A., Maitra A., and Mendell J.T. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26 (2007) 745-752
52. Xi Y., Shalgi R., Fodstad O., Pilpel Y., and Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin. Cancer Res. 12 (2006) 2014-2024
53. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133 (2008) 217-222
54. Egle A., Harris A.W., Bouillet P., and Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA 101 (2004) 6164-6169
55. Cheng A.M., Byrom M.W., Shelton J., and Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucl. Acids Res. 33 (2005) 1290-1297
56. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., and Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283 (2008) 1026-1033
57. Loffler D., Brocke-Heidrich K., Pfeifer G., Stocsits C., Hackermuller J., Kretzschmar A.K., Burger R., Gramatzki M., Blumert C., Bauer K., Cvijic H., Ullmann A.K., Stadler P.F., and Horn F. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110 (2007) 1330-1333
58. Gramantieri L., Fornari F., Callegari E., Sabbioni S., Lanza G., Croce C.M., Bolondi L., and Negrini M. MicroRNA involvement in hepatocellular carcinoma. J. Cell. Mol. Med. 12 (2008) 2189-2204
59. Schickel R., Boyerinas B., Park S.M., and Peter M.E. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27 (2008) 5959-5974
60. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
61. Hahn W.C., and Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2 (2002) 331-341
62. Benetti R., Gonzalo S., Jaco I., Munoz P., Gonzalez S., Schoeftner S., Murchison E., Andl T., Chen T., Klatt P., Li E., Serrano M., Millar S., Hannon G., and Blasco M.A. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol. 15 (2008) 268-279
63. Lal A., Kim H.H., Abdelmohsen K., Kuwano Y., Pullmann Jr. R., Srikantan S., Subrahmanyam R., Martindale J.L., Yang X., Ahmed F., Navarro F., Dykxhoorn D., Lieberman J., and Gorospe M. p16(INK4a) translation suppressed by miR-24. PLoS ONE 3 (2008) e1864
64. Tazawa H., Tsuchiya N., Izumiya M., and Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA 104 (2007) 15472-15477
65. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
66. Kuehbacher A., Urbich C., Zeiher A.M., and Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101 (2007) 59-68
67. Chen Y., and Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111 (2008) 1217-1226
68. Kuehbacher A., Urbich C., and Dimmeler S. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol. Sci. 29 (2008) 12-15
69. Fish J.E., and Srivastava D. MicroRNAs: opening a new vein in angiogenesis research. Sci. Signal 2 (2008) pe1
70. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., and Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 1 (2006) e116
71. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y., and Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15 (2008) 272-284
72. Wang S., Aurora A.B., Johnson B.A., Qi X., McAnally J., Hill J.A., Richardson J.A., Bassel-Duby R., and Olson E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15 (2008) 261-271
73. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., Furth E.E., Lee W.M., Enders G.H., Mendell J.T., and Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38 (2006) 1060-1065
74. Lee D.Y., Deng Z., Wang C.H., and Yang B.B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. USA 104 (2007) 20350-20355
75. Wurdinger T., Tannous B.A., Saydam O., Skog J., Grau S., Soutschek J., Weissleder R., Breakefield X.O., and Krichevsky A.M. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14 (2008) 382-393
76. Jiang J., Lee E.J., Gusev Y., and Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucl. Acids Res. 33 (2005) 5394-5403
77. Whiteside T.L. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27 (2008) 5904-5912
78. Lindsay M.A. microRNAs and the immune response. Trends Immunol. 29 (2008) 343-351
79. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., and Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007) 608-611
80. Taganov K.D., Boldin M.P., Chang K.J., and Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103 (2006) 12481-12486
81. Li Q.J., Chau J., Ebert P.J., Sylvester G., Min H., Liu G., Braich R., Manoharan M., Soutschek J., Skare P., Klein L.O., Davis M.M., and Chen C.Z. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129 (2007) 147-161
82. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., and Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 316 (2007) 604-608
83. Pedersen I., and David M. MicroRNAs in the immune response. Cytokine 43 (2008) 391-394
84. Williams A.E., Perry M.M., Moschos S.A., Larner-Svensson H.M., and Lindsay M.A. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem. Soc. Trans. 36 (2008) 1211-1215
85. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., and Croce C.M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103 (2006) 7024-7029
86. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102 (2005) 3627-3632
87. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., Jaenisch R., Sharp P.A., and Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132 (2008) 875-886
88. Stern-Ginossar N., Gur C., Biton M., Horwitz E., Elboim M., Stanietsky N., Mandelboim M., and Mandelboim O. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol. 9 (2008) 1065-1073
89. Sullivan C.S., Grundhoff A.T., Tevethia S., Pipas J.M., and Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435 (2005) 682-686
90. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
91. Moreno-Bueno G., Portillo F., and Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27 (2008) 6958-6969
92. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12 (2006) 895-904
93. Ma C., Rong Y., Radiloff D.R., Datto M.B., Centeno B., Bao S., Cheng A.W., Lin F., Jiang S., Yeatman T.J., and Wang X.F. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22 (2008) 308-321
94. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-688
95. Steeg P.S. Cancer: micromanagement of metastasis. Nature 449 (2007) 671-673
96. Bracken C.P., Gregory P.A., Khew-Goodall Y., and Goodall G.J. The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell. Mol. Life Sci. (2009) Epub ahead of print
97. Zhu S., Si M.L., Wu H., and Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282 (2007) 14328-14336
98. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., and Shao J.Y. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (2008) 2348-2360
99. Zhu S., Wu H., Wu F., Nie D., Sheng S., and Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18 (2008) 350-359
100. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., and Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27 (2008) 2128-2136
101. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Pure E., and Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 10 (2008) 202-210
102. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
103. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., Brenner J.C., Yu J., Kim J.H., Han B., Tan P., Kumar-Sinha C., Lonigro R.J., Palanisamy N., Maher C.A., and Chinnaiyan A.M. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322 (2008) 1695-1699
104. Gregory P.A., Bracken C.P., Bert A.G., and Goodall G.J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7 (2008) 3112-3118
105. Cano A., and Nieto M.A. Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition. Trends Cell Biol. 18 (2008) 357-359
106. Ma L., and Weinberg R.A. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet. 24 (2008) 448-456
107. Polyak K., and Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9 (2009) 265-273
108. Park S.M., Gaur A.B., Lengyel E., and Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22 (2008) 894-907
109. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., and Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10 (2008) 593-601
110. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., and Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9 (2008) 582-589
111. Hurteau G.J., Carlson J.A., Spivack S.D., and Brock G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 67 (2007) 7972-7976
112. Korpal M., Lee E.S., Hu G., and Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283 (2008) 14910-14914
113. Kong W., Yang H., He L., Zhao J.J., Coppola D., Dalton W.S., and Cheng J.Q. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28 (2008) 6773-6784
114. Pickering M.T., Stadler B.M., and Kowalik T.F. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28 (2009) 140-145
115. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., and Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101 (2004) 2999-3004
116. Sevignani C., Calin G.A., Nnadi S.C., Shimizu M., Davuluri R.V., Hyslop T., Demant P., Croce C.M., and Siracusa L.D. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc. Natl. Acad. Sci. USA 104 (2007) 8017-8022
117. Neiman P.E., Elsaesser K., Loring G., and Kimmel R. Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis. PLoS Genet. 4 (2008) e1000132
118. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., Liang S., Naylor T.L., Barchetti A., Ward M.R., Yao G., Medina A., O'Brien-Jenkins A., Katsaros D., Hatzigeorgiou A., Gimotty P.A., Weber B.L., and Coukos G. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 103 (2006) 9136-9141
119. Tagawa H., and Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19 (2005) 2013-2016
120. Yang J., Zhou F., Xu T., Deng H., Ge Y.Y., Zhang C., Li J., and Zhuang S.M. Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas. Mutat. Res. 638 (2008) 205-209
121. Diederichs S., and Haber D.A. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res. 66 (2006) 6097-6104
122. Huppi K., Volfovsky N., Mackiewicz M., Runfola T., Jones T.L., Martin S.E., Stephens R., and Caplen N.J. MicroRNAs and genomic instability. Semin. Cancer Biol. 17 (2007) 65-73
123. Calin G.A., and Croce C.M. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25 (2006) 6202-6210
124. Lee Y.S., and Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21 (2007) 1025-1030
125. Kroemer G., and Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13 (2008) 472-482
126. Yeung S.J., Pan J., and Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 65 (2008) 3981-3999
127. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., and Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004) 226-230
128. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., and Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 (2006) 87-98
129. Xu P., Vernooy S.Y., Guo M., and Hay B.A. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 13 (2003) 790-795
130. Varghese J., and Cohen S.M. microRNA miR-14 acts to modulate a positive autoregulatory loop controlling steroid hormone signaling in Drosophila. Genes Dev. 21 (2007) 2277-2282
131. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., and Dang C.V. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458 (2009) 762-765
132. Deberardinis R.J., Sayed N., Ditsworth D., and Thompson C.B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18 (2008) 54-61
133. DeBerardinis R.J. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet. Med. 10 (2008) 767-777
134. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
135. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., and Croce C.M. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353 (2005) 1793-1801
136. Nelson P.T., Baldwin D.A., Scearce L.M., Oberholtzer J.C., Tobias J.W., and Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods 1 (2004) 155-161
137. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Zen K., and Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18 (2008) 997-1006
138. Weiler J., Hunziker J., and Hall J. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?. Gene Ther. 13 (2006) 496-502
139. Hutvagner G., Simard M.J., Mello C.C., and Zamore P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2 (2004) E98
140. Meister G., Landthaler M., Dorsett Y., and Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10 (2004) 544-550
141. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
142. Ivan M., Harris A.L., Martelli F., and Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. J. Cell. Mol. Med. 12 (2008) 1426-1431
143. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., Davuluri R., Liu C.G., Croce C.M., Negrini M., Calin G.A., and Ivan M. A microRNA signature of hypoxia. Mol. Cell. Biol. 27 (2007) 1859-1867
144. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S., and Calin G.A. MicroRNAs - the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9 (2009) 293-302